ERD

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer The...

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and M...

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 exp...

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Immuno-Oncology beyond TILs: Unleashing TILCs

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Therapeutic blockade of activin-A improves NK cell function and antitumor immunity

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Inherited IL-18BP deficiency in human fulminant viral hepatitis

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Nouvelles frontières de la lutte contre le cancer

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Role Of The Itam-Bearing Receptors Expressed By Natural Killer Cells In Cancer

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Maternal diesel particle exposure promotes offspring asthma through NK cell–derived granzyme B

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Periodic Reporting for period 3 - TILC (Targeting Innate Lymphoid Cells)

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signat...

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Tra...

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

ILC3s control splenic cDC homeostasis via lymphotoxin signaling

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Innate Lymphoid Cells: 10 Years On

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Role of NKp46 + natural killer cells in house dust mite‐driven asthma

Project: TILC

Updated at: 27-04-2024

Show more information

Project acronym TILC

Resources

Selected filters:

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer The...

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and M...

Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 exp...

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection

Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19

c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice

Immuno-Oncology beyond TILs: Unleashing TILCs

A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets

The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF

Therapeutic blockade of activin-A improves NK cell function and antitumor immunity

Inherited IL-18BP deficiency in human fulminant viral hepatitis

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Nouvelles frontières de la lutte contre le cancer

Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers

Role Of The Itam-Bearing Receptors Expressed By Natural Killer Cells In Cancer

Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells

Maternal diesel particle exposure promotes offspring asthma through NK cell–derived granzyme B

Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

Periodic Reporting for period 3 - TILC (Targeting Innate Lymphoid Cells)

Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signat...

Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Tra...

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

ILC3s control splenic cDC homeostasis via lymphotoxin signaling

Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo

Innate Lymphoid Cells: 10 Years On

Role of NKp46 + natural killer cells in house dust mite‐driven asthma